Application and Rationality Evaluation of Hemostatic Drugs in the Patients with Subarachnoid Hemorrhage
- VernacularTitle:止血药在蛛网膜下腔出血患者中的应用调查和合理性评价
- Author:
Juan ZHAO
1
;
Jianqun XIONG
;
Yan CHEN
;
Yuanrong YANG
Author Information
1. 荆州市中心医院药学部 湖北荆州434020
- Keywords:
Hemostatics;
Subarachnoid hemorrhage;
Rational drug use;
Drug utilization
- From:
China Pharmacist
2018;21(2):279-281
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the current use situation of hemostatics in preventing re-bleeding in the patients with sub-arachnoid hemorrhage. Methods:The records of patients with subarachnoid hemorrhage were selected from a hospital in 2016 and the types,dosage,course and drug adverse reactions of hemostatics were recorded and evaluated according to the drug information leaflets/related guideline,drug utilization researches and adverse drug actions monitoring. Results:Totally 81 cases with hemostatics involved 3 varieties of hemostatic drugs,the combination proportion was 16.05%,the reasonable use rate was 86.42%,the reasonable rate of administration route was 100%,the reasonable solvent rate was 98.77% and the course no more than 72 h was 88.89%. The drug uti-lization index of etamsylate injection and tranexamic acid injection was greater than one,indicating that the dosage was unreasonable. There were no adverse reactions in the 81 cases.Conclusion:The use of hemostatics in the patients with subarachnoid hemorrhage is common,and there is still unreasonable use (such as dosage and course etc) that we should pay attention to.
